{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65113e2e092080001142172a/6adf69e2dd08c5f770d9c2d5?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"INR stories: Frédéric Clarençon's uncensored interview","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/65113e2e092080001142172a/1793024281303-2c4022b5-31e5-464a-ae0e-23a1b62525bf.jpeg?height=200","description":"<h3>In this episode of INR Stories, Nanthiya Sujijantarat speaks with Frédéric Clarençon, Head of Interventional Neuroradiology at La Pitié-Salpêtrière Hospital in Paris. From his early fascination with catheter-based therapies to leadership in major neurointerventional trials, he reflects on AVM management, distal thrombectomy, chronic subdural hematoma embolization, mentorship, and the future role of robotics and AI in the specialty.</h3><p><br></p><p><strong>Key topics discussed</strong></p><ul><li>Evolving treatment strategies for brain and spinal AVMs, including dual-lumen balloon techniques and embolization-first approaches.</li><li>The rationale behind the DISCOUNT trial and the ongoing debate around thrombectomy for distal vessel occlusions.</li><li>Lessons from the negative EMPROTECT trial and what they mean for MMA embolization in chronic subdural hematoma.</li><li>Memorable cases, vasospasm management, and how clinical practice has evolved over the past 16 years.</li><li>Why anatomy and pathophysiology remain the foundation of better treatment decisions and patient outcomes.</li></ul>","author_name":"LINNC online"}